If you are a HCP in the US, you can be redirected to a HCP version of this page by clicking 'yes'
Lactobacillus rhamnosus, LGG® is the world’s most documented probiotic strain. The LGG® strain has proven benefits across all ages and numerous health areas, including gastrointestinal, immune and oral health.
LGG® is a trademark of Chr. Hansen A/S
The probiotic strain Bifidobacterium, BB-12® is the world’s most documented probiotic Bifidobacterium. It has been extensively studied and has been associated with improved outcomes across various areas of health.
BB-12® is a trademark of Chr. Hansen A/S
The probiotic strain Bifidobacterium infantis (DSM 33361) has been studied in preterm infants in several clinical trials. It is a promising infant strain as it has the right characteristics to support healthy infant gut development.
The probiotic strain Lactobacillus paracasei, L. CASEI 431® has demonstrated improvements to immune health in high-quality, human clinical studies.
L. CASEI 431® is a trademark of Chr. Hansen A/S
The UREX™ blend is a combination of two probiotic bacterial strains, Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®. UREX™ has been associated with supporting female urogenital health.
UREX™, GR-1® and RC-14® are trademarks of Chr. Hansen A/S
The probiotic strain Lactobacillus acidophilus, LA-5® has demonstrated benefits, for example, in gastrointestinal health when used in combination with Bifidobacterium, BB-12®.
LA-5® and BB-12® are trademarks of Chr. Hansen A/S